Biogen Earnings
NASDAQ: BIIBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Oct 28, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$2.10
Biogen earnings summary
Biogen is scheduled to report Sep/2026 earnings on Oct 28, 2026 before the market opens, with analysts expecting EPS of $2.10. In its most recent report on Apr 29, 2026 (Q1 2026), BIIB posted EPS of $2.15. Revenue for the quarter was $2.48 billion.
Quarterly EPS is up 31.1% from the same quarter a year earlier. Across the last 16 reports, BIIB shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
BIIB earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Apr 29, 2026 | — | $2.15 | — | +3.4% |
| Feb 6, 2026 | — | $-0.35 | — | -2.3% |
| Oct 30, 2025 | — | $3.17 | — | +0.8% |
| Jul 31, 2025 | — | $4.33 | — | -1.0% |
| May 1, 2025 | — | $1.64 | — | -4.3% |
| Feb 12, 2025 | — | $1.82 | — | +2.4% |
| Oct 30, 2024 | — | $2.66 | — | -0.4% |
| Aug 1, 2024 | — | $4.00 | — | -1.8% |
| Apr 24, 2024 | — | $2.70 | — | +4.1% |
| Feb 14, 2024 | — | $1.70 | — | +1.9% |
| Nov 8, 2023 | — | $-0.47 | — | +1.4% |
| Jul 25, 2023 | — | $4.07 | — | +1.4% |
| Apr 25, 2023 | — | $2.67 | — | +4.5% |
| Feb 15, 2023 | — | $3.73 | — | -3.0% |
| Oct 25, 2022 | — | $7.84 | — | -0.9% |
| Jul 20, 2022 | — | $7.24 | — | +4.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.